Donald Trump has announced a dramatic shake-up in U.S. drug pricing. On Monday, he is expected to sign an executive order that could slash prescription drug prices by up to 80%. The news sent shockwaves across Asian markets, with pharmaceutical stocks plunging in early trading.

“America Will Never Pay More Than the Lowest Price Again”

Trump made the announcement via Truth Social, vowing that Americans will no longer be held hostage by pharmaceutical giants. The upcoming policy would guarantee that the U.S. pays no more than the lowest price any country pays for the same drug.

“We’re doing what Democrats have been talking about for years — but never delivered,” Trump wrote. He emphasized that this time, lobbying pressure from drug companies won't stop him, as it did during his first term.

Asian Markets React: Pharma Stocks in Free Fall

Markets wasted no time responding. Japan’s Chugai Pharmaceutical saw its shares drop by 7.2% — the steepest decline in a month. Takeda and Daiichi Sankyo fell over 5%, while Samsung Biologics, SK Biopharmaceuticals, and Celltrion in South Korea lost more than 3%.

Analysts warn that if the U.S. truly moves forward with aggressive price cuts, it could trigger tougher negotiations globally, squeezing profit margins for drugmakers who rely heavily on U.S. revenue to fund research and innovation.

Trump: “America Will No Longer Pay the Bill for the World”

Trump also took aim at the industry’s longstanding claim that high U.S. drug prices are needed to cover R&D costs. “America won’t be footing the bill for the world anymore,” he declared. “We’re setting fair terms — finally.”

What’s Next?

The full text of the executive order has yet to be released. Legal teams and lobbyists are already preparing for a possible court challenge.

All eyes are on Monday — and whether Trump’s signature will ignite a long legal battle, or spark a real breakthrough for American families struggling with high pharmacy bills.


#TRUMP , #worldnews , #GlobalMarkets , #TradingCommunity , #stockmarket


Stay one step ahead – follow our profile and stay informed about everything important in the world of cryptocurrencies!

Notice:

,,The information and views presented in this article are intended solely for educational purposes and should not be taken as investment advice in any situation. The content of these pages should not be regarded as financial, investment, or any other form of advice. We caution that investing in cryptocurrencies can be risky and may lead to financial losses.“